| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |